<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Aprotinin,Aprotinin.png,2004,2006,ATC code B02,Acute pancreatitis,Acute renal failure,Alanine,Amino acid,Anaphylaxis,Anatomical Therapeutic Chemical Classification System" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Aprotinin - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Aprotinin</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="../../../a/p/r/Image%7EAprotinin.png_af38.html" class="image" title=""><img src="../../../upload/thumb/3/34/Aprotinin.png/181px-Aprotinin.png" alt="" width="181" height="187" longdesc="../../../a/p/r/Image%7EAprotinin.png_af38.html" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Aprotinin</div>
</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="../../../i/n/t/International_Union_of_Pure_and_Applied_Chemistry_nomenclature_efd4.html" title="International Union of Pure and Applied Chemistry nomenclature">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">Aprotinin</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="../../../c/a/s/CAS_registry_number_4b20.html" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=9087-70-1&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=9087-70-1&amp;rn=1" rel="nofollow">9087-70-1</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../a/n/a/Anatomical_Therapeutic_Chemical_Classification_System_186e.html" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="../../../a/t/c/ATC_code_B02_1d52.html" title="ATC code B02">B02</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=B02AB01" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=B02AB01" rel="nofollow">AB01</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../p/u/b/PubChem_a50b.html" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=N/A" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=N/A" rel="nofollow">N/A</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../c/h/e/Chemical_formula.html" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="../../../c/a/r/Carbon.html" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>284</sub><a href="../../../h/y/d/Hydrogen.html" title="Hydrogen"><span style="color: rgb(154,154,154); font-weight: bold;">H</span></a><sub>432</sub><a href="../../../n/i/t/Nitrogen.html" title="Nitrogen"><span style="color: rgb(000,000,255); font-weight: bold;">N</span></a><sub>84</sub><a href="../../../o/x/y/Oxygen.html" title="Oxygen"><span style="color: rgb(232,070,070); font-weight: bold;">O</span></a><sub>79</sub><a href="../../../s/u/l/Sulfur.html" title="Sulfur"><span style="color: rgb(229,197,063); font-weight: bold;">S</span></a><sub>7</sub><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../m/o/l/Molecular_mass.html" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">6511.51</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../s/y/n/Synonym.html" title="Synonym">Synonyms</a></td>
<td bgcolor="#EEEEEE">trasylol, bovine pancreatic trypsin inhibitor</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Bioavailability.html" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">100% (IV)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../d/r/u/Drug_metabolism.html" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Biological_half-life.html" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../e/x/c/Excretion.html" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/r/e/Pregnancy_category.html" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>X</p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/e/g/Regulation_of_therapeutic_goods.html" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p>RX/POM</p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top; white-space: nowrap;">Dependence Liability</td>
<td bgcolor="#EEEEEE" style="vertical-align: top;">none</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/o/u/Route_of_administration.html" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">intravenous</td>
</tr>
</table>
<p><b>Aprotinin</b>, also known as <b>bovine pancreatic trypsin inhibitor, BPTI</b> (TrasylolÂ®, <a href="../../../b/a/y/Bayer.html" title="Bayer">Bayer</a>) is a protein, that is used as <a href="../../../m/e/d/Medication.html" title="Medication">medication</a> administered by <a href="../../../i/n/j/Injection_%28medicine%29.html" title="Injection (medicine)">injection</a> to reduce <a href="../../../b/l/e/Bleeding.html" title="Bleeding">bleeding</a> during complex <a href="../../../s/u/r/Surgery.html" title="Surgery">surgery</a>, such as heart and liver surgery. Its main effect is the slowing down of <a href="../../../f/i/b/Fibrinolysis.html" title="Fibrinolysis">fibrinolysis</a>, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for <a href="../../../b/l/o/Blood_transfusion.html" title="Blood transfusion">blood transfusions</a> during surgery, as well as end-organ damage due to <a href="../../../h/y/p/Hypotension.html" title="Hypotension">hypotension</a> (low blood pressure) as a result of marked blood loss.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Chemistry"><span class="tocnumber">1</span> <span class="toctext">Chemistry</span></a></li>
<li class="toclevel-1"><a href="#Mechanism_of_action"><span class="tocnumber">2</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1"><a href="#Efficacy"><span class="tocnumber">3</span> <span class="toctext">Efficacy</span></a></li>
<li class="toclevel-1"><a href="#Safety"><span class="tocnumber">4</span> <span class="toctext">Safety</span></a></li>
<li class="toclevel-1"><a href="#In_vitro_use"><span class="tocnumber">5</span> <span class="toctext">In vitro use</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">6</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Chemistry" id="Chemistry"></a></p>
<h2><span class="editsection">[<a href="../../../a/p/r/Aprotinin.html" title="Edit section: Chemistry">edit</a>]</span> <span class="mw-headline">Chemistry</span></h2>
<p>Aprotinin is a monomeric (single-chain) globular <a href="../../../p/o/l/Polypeptide.html" title="Polypeptide">polypeptide</a> derived from bovine lung tissue; it has a <a href="../../../m/o/l/Molecular_weight.html" title="Molecular weight">molecular weight</a> of 6512 and consists of 16 different <a href="../../../a/m/i/Amino_acid.html" title="Amino acid">amino acids</a> arranged in a chain of 58 amino acid residues.<sup id="_ref-Mannucci_0" class="reference"><a href="#_note-Mannucci" title="">[1]</a></sup><sup id="_ref-Mahdy_0" class="reference"><a href="#_note-Mahdy" title="">[2]</a></sup>.</p>
<p>Its amino acid sequence is RPDFC LEPPY TGPCK ARIIR YFYNA KAGLC QTFVY GGCRA KRNNF KSAED CMRTC GGA.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[3]</a></sup></p>
<p>The stability of the molecule is due to the 3 <a href="../../../d/i/s/Disulfide_bond.html" title="Disulfide bond">disulfide bonds</a> linking the 6 <a href="../../../c/y/s/Cysteine.html" title="Cysteine">cysteine</a> members of the chain (Cys5-Cys55, Cys14-Cys38 and Cys30-Cys51).<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[4]</a></sup> The <a href="../../../l/y/s/Lysine.html" title="Lysine">lysine</a> (15)-<a href="../../../a/l/a/Alanine.html" title="Alanine">alanine</a> (16) sequence on this strongly basic polypeptide represents the active centre.</p>
<p>Aprotinin is the <a href="../../../a/x/i/Axiom.html" title="Axiom">axiomic</a> member of the protein family of Kunitz-type <a href="../../../s/e/r/Serine_protease_inhibitor.html" title="Serine protease inhibitor">serine protease inhibitors</a>.</p>
<p>It is one of the most thoroughly studied proteins in terms of structure and <a href="../../../p/r/o/Protein_folding.html" title="Protein folding">folding pathway</a>. BPTI was one of the first proteins to have its <a href="../../../p/r/o/Protein_structure.html" title="Protein structure">structure</a> solved by <a href="../../../p/r/o/Protein_nuclear_magnetic_resonance_spectroscopy.html" title="Protein nuclear magnetic resonance spectroscopy">NMR spectroscopy</a>. Nevertheless, its physiological function remains unknown.</p>
<p><a name="Mechanism_of_action" id="Mechanism_of_action"></a></p>
<h2><span class="editsection">[<a href="../../../a/p/r/Aprotinin.html" title="Edit section: Mechanism of action">edit</a>]</span> <span class="mw-headline">Mechanism of action</span></h2>
<p>Aprotinin inhibits several <a href="../../../s/e/r/Serine_protease.html" title="Serine protease">serine proteases</a>, specifically <a href="../../../t/r/y/Trypsin.html" title="Trypsin">trypsin</a>, <a href="../../../c/h/y/Chymotrypsin.html" title="Chymotrypsin">chymotrypsin</a> and <a href="../../../p/l/a/Plasmin.html" title="Plasmin">plasmin</a> at a concentration of about 125,000 IU/ml, and <a href="../../../k/a/l/Kallikrein.html" title="Kallikrein">kallikrein</a> at 300,000 IU/ml<sup id="_ref-Mahdy_1" class="reference"><a href="#_note-Mahdy" title="">[2]</a></sup>. Its action on <a href="../../../k/a/l/Kallikrein.html" title="Kallikrein">kallikrein</a> leads to the inhibition of the formation of <a href="../../../f/a/c/Factor_XII_5139.html" title="Factor XII">factor XIIa</a>. As a result, both the intrinsic pathway of coagulation and fibrinolysis are inhibited. Its action on plasmin independently slows fibrinolysis<sup id="_ref-Mannucci_1" class="reference"><a href="#_note-Mannucci" title="">[1]</a></sup>.</p>
<p><a name="Efficacy" id="Efficacy"></a></p>
<h2><span class="editsection">[<a href="../../../a/p/r/Aprotinin.html" title="Edit section: Efficacy">edit</a>]</span> <span class="mw-headline">Efficacy</span></h2>
<p>In cardiac surgery with a high risk of significant blood loss, aprotinin significantly reduced bleeding, mortality and hospital stay<sup id="_ref-Mahdy_2" class="reference"><a href="#_note-Mahdy" title="">[2]</a></sup>. Beneficial effects were also reported in high-risk orthopedic surgery<sup id="_ref-Mahdy_3" class="reference"><a href="#_note-Mahdy" title="">[2]</a></sup>. In <a href="../../../l/i/v/Liver_transplantation.html" title="Liver transplantation">liver transplantation</a>, initial reports of benefit were overshadowed by concerns about toxicity<sup id="_ref-Xia_0" class="reference"><a href="#_note-Xia" title="">[5]</a></sup>.</p>
<p>In a <a href="../../../m/e/t/Meta-analysis.html" title="Meta-analysis">meta-analysis</a> performed in <a href="../../../2/0/0/2004.html" title="2004">2004</a>, transfusion requirements decreased by 39% in <a href="../../../c/o/r/Coronary_artery_bypass_graft.html" title="Coronary artery bypass graft">coronary artery bypass graft</a> (CABG) surgery<sup id="_ref-Sedrakyan_0" class="reference"><a href="#_note-Sedrakyan" title="">[6]</a></sup>. In orthopedic surgery, a decrease of blood transfusions was likewise confirmed<sup id="_ref-Shiga_0" class="reference"><a href="#_note-Shiga" title="">[7]</a></sup>.</p>
<p><a name="Safety" id="Safety"></a></p>
<h2><span class="editsection">[<a href="../../../a/p/r/Aprotinin.html" title="Edit section: Safety">edit</a>]</span> <span class="mw-headline">Safety</span></h2>
<p>There have been concerns about the safety of aprotinin<sup id="_ref-Mahdy_4" class="reference"><a href="#_note-Mahdy" title="">[2]</a></sup>. <a href="../../../a/n/a/Anaphylaxis.html" title="Anaphylaxis">Anaphylaxis</a> (a severe allergic reaction) occurs at a rate of 1:200 in first-time use, but <a href="../../../s/e/r/Serology.html" title="Serology">serology</a> (measuring antibodies against aprotinin in the blood) is not carried out in practice to predict anaphylaxis risk because the correct interpretation of these tests is difficult.<sup id="_ref-Mahdy_5" class="reference"><a href="#_note-Mahdy" title="">[2]</a></sup></p>
<p><a href="../../../t/h/r/Thrombosis.html" title="Thrombosis">Thrombosis</a>, presumably from overactive inhibition of the fibrinolytic system, may occur at a higher rate, but until 2006 there was limited evidence for this association<sup id="_ref-Mahdy_6" class="reference"><a href="#_note-Mahdy" title="">[2]</a></sup><sup id="_ref-Sedrakyan_1" class="reference"><a href="#_note-Sedrakyan" title="">[6]</a></sup>. Similarly, while biochemical measures of renal function were known to occasionally deteriorate, there was no evidence that this greatly influenced outcomes<sup id="_ref-Mahdy_7" class="reference"><a href="#_note-Mahdy" title="">[2]</a></sup>. A study performed in cardiac surgery patients reported in 2006 showed that there was indeed a risk of <a href="../../../a/c/u/Acute_renal_failure.html" title="Acute renal failure">acute renal failure</a>, <a href="../../../m/y/o/Myocardial_infarction.html" title="Myocardial infarction">myocardial infarction</a> and <a href="../../../h/e/a/Heart_failure.html" title="Heart failure">heart failure</a>, as well as <a href="../../../s/t/r/Stroke.html" title="Stroke">stroke</a> and <a href="../../../e/n/c/Encephalopathy.html" title="Encephalopathy">encephalopathy</a><sup id="_ref-Mangano_0" class="reference"><a href="#_note-Mangano" title="">[8]</a></sup> The study authors recommend older antifibrinolytics (such as <a href="../../../t/r/a/Tranexamic_acid.html" title="Tranexamic acid">tranexamic acid</a>) in which these risks were not documented<sup id="_ref-Mangano_1" class="reference"><a href="#_note-Mangano" title="">[8]</a></sup>. The same group updated their data in 2007 and demonstrated similar findings.<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[9]</a></sup></p>
<p>In September 2006, Bayer A.G. was faulted by the FDA for not revealing during testimony the existence of a commissioned retrospective study of 67,000 patients, 30,000 of whom received Trasylol and the rest other anti-fibrinolytics. The study concluded Trasylol carried greater risks. The FDA was alerted to the study by one of the researchers involved. Although the FDA issued a statement of concern they did not change their recommendation that the drug may benefit certain subpopulations of patients.<sup id="_ref-3" class="reference"><a href="#_note-3" title="">[10]</a></sup> In a Public Health Advisory Update dated <a href="../../../o/c/t/October_3.html" title="October 3">October 3</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>, the FDA recommended that "physicians consider limiting Trasylol use to those situations in which the clinical benefit of reduced blood loss is necessary to medical management and outweighs the potential risks" and carefully monitor patients. <sup id="_ref-4" class="reference"><a href="#_note-4" title="">[11]</a></sup></p>
<p>On October 29, 2006 the Food and Drug Administration issued a warning that aprotinin may have serious kidney and cardiovascular toxicity. The producer, Bayer, reported to the FDA that additional observation studies showed that it may increase the chance for death, serious kidney damage, congestive heart failure and strokes. FDA warned clinicians to consider limiting use to those situations where the clinical benefit of reduced blood loss is essential to medical management and outweighs the potential risks.<sup id="_ref-5" class="reference"><a href="#_note-5" title="">[12]</a></sup></p>
<p>No cases of <a href="../../../b/o/v/Bovine_spongiform_encephalopathy.html" title="Bovine spongiform encephalopathy">bovine spongiform encephalopathy</a> transmission by aprotinin have been reported, although the drug was withdrawn in Italy due to fears of this <sup id="_ref-Mahdy_8" class="reference"><a href="#_note-Mahdy" title="">[2]</a></sup>.</p>
<p><a name="In_vitro_use" id="In_vitro_use"></a></p>
<h2><span class="editsection">[<a href="../../../a/p/r/Aprotinin.html" title="Edit section: In vitro use">edit</a>]</span> <span class="mw-headline">In vitro use</span></h2>
<p>Small amounts of aprotinin can be added to tubes of drawn blood to enable laboratory measurement of certain rapidly degraded proteins such as <a href="../../../g/l/u/Glucagon.html" title="Glucagon">glucagon</a>.</p>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="../../../a/p/r/Aprotinin.html" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>Initially named "kallikrein inactivator", aprotinin was first isolated from cow <a href="../../../p/a/r/Parotid_gland.html" title="Parotid gland">parotid glands</a> in 1928<sup id="_ref-6" class="reference"><a href="#_note-6" title="">[13]</a></sup> and independently as "bovine pancreatic trypsin inhibitor" from cow pancreas in 1936.<sup id="_ref-7" class="reference"><a href="#_note-7" title="">[14]</a></sup> It was purified from bovine lung in 1964.<sup id="_ref-8" class="reference"><a href="#_note-8" title="">[15]</a></sup> As it inhibits pancreatic enzymes, it was initially used in the treatment for <a href="../../../a/c/u/Acute_pancreatitis.html" title="Acute pancreatitis">acute pancreatitis</a>, in which destruction of the gland by its own enzymes is thought to be part of the pathogenesis.<sup id="_ref-9" class="reference"><a href="#_note-9" title="">[16]</a></sup> Its use in major surgery commenced in the 1960s.<sup id="_ref-10" class="reference"><a href="#_note-10" title="">[17]</a></sup></p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/p/r/Aprotinin.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ol class="references">
<li id="_note-Mannucci">^ <a href="#_ref-Mannucci_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Mannucci_1" title=""><sup><i><b>b</b></i></sup></a> Mannucci PM. Hemostatic drugs. <i>N Engl J Med</i> 1998;339:245-53. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9673304" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9673304">PMID 9673304</a>.</li>
<li id="_note-Mahdy">^ <a href="#_ref-Mahdy_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Mahdy_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-Mahdy_2" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-Mahdy_3" title=""><sup><i><b>d</b></i></sup></a> <a href="#_ref-Mahdy_4" title=""><sup><i><b>e</b></i></sup></a> <a href="#_ref-Mahdy_5" title=""><sup><i><b>f</b></i></sup></a> <a href="#_ref-Mahdy_6" title=""><sup><i><b>g</b></i></sup></a> <a href="#_ref-Mahdy_7" title=""><sup><i><b>h</b></i></sup></a> <a href="#_ref-Mahdy_8" title=""><sup><i><b>i</b></i></sup></a> Mahdy AM, Webster NR. Perioperative systemic haemostatic agents. <i>Br J Anaesth</i> 2004;93:842-58. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15277296" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15277296">PMID 15277296</a>.</li>
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> Kassell B, Radicevic M, Ansfield MJ, Laskowski Sr M. The basic trypsin inhibitor of bovine pancreas IV. The linear sequence of the 58 amino acids. <i>Biochem Biophys Res Commun</i> 1965;18:255-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14282026" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14282026">PMID 14282026</a>.</li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> Kassell B, Laskowski M Sr. The basic trypsin inhibitor of bovine pancreas. V. The disulfide linkages. <i>Biochem Biophys Res Commun</i> 1965;20:463-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=5860161" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=5860161">PMID 5860161</a>.</li>
<li id="_note-Xia"><b><a href="#_ref-Xia_0" title="">^</a></b> Xia VW, Steadman RH. Antifibrinolytics in orthotopic liver transplantation: current status and controversies. <i>Liver Transpl</i> 2005;11:10-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15690531" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15690531">PMID 15690531</a>.</li>
<li id="_note-Sedrakyan">^ <a href="#_ref-Sedrakyan_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Sedrakyan_1" title=""><sup><i><b>b</b></i></sup></a> Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. <i>J Thorac Cardiovasc Surg</i> 2004;128:442-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15354106" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15354106">PMID 15354106</a>.</li>
<li id="_note-Shiga"><b><a href="#_ref-Shiga_0" title="">^</a></b> Shiga T, Wajima Z, Inoue T, Sakamoto A. Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials. <i>Anesth Analg</i> 2005;101:1602-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16301226" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16301226">PMID 16301226</a>.</li>
<li id="_note-Mangano">^ <a href="#_ref-Mangano_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Mangano_1" title=""><sup><i><b>b</b></i></sup></a> Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. <i>N Engl J Med</i> 2006;354:353-65. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16436767" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16436767">PMID 16436767</a>.</li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> <cite style="font-style:normal">Mangano D, Miao Y, Vuylsteke A, Tudor I, Juneja R, Filipescu D, Hoeft A, Fontes M, Hillel Z, Ott E, Titov T, Dietzel C, Levin J (2007). "Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery". <i>JAMA</i> <b>297</b> (5): 471-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17284697" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17284697">PMID 17284697</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Mortality+associated+with+aprotinin+during+5+years+following+coronary+artery+bypass+graft+surgery&amp;rft.title=JAMA&amp;rft.jtitle=JAMA&amp;rft.date=2007&amp;rft.volume=297&amp;rft.issue=5&amp;rft.au=Mangano+D%2C+Miao+Y%2C+Vuylsteke+A%2C+Tudor+I%2C+Juneja+R%2C+Filipescu+D%2C+Hoeft+A%2C+Fontes+M%2C+Hillel+Z%2C+Ott+E%2C+Titov+T%2C+Dietzel+C%2C+Levin+J&amp;rft.pages=471-9&amp;rft_id=info:pmid/17284697">&#160;</span></li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> Gardiner Harris. F.D.A. says Bayer Failed to Reveal Drug Risk Study. New York Times; September 30, 2006</li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> <a href="http://factsandcomparisons.com/News/ArticlePage.aspx?id=7387" class="external text" title="http://factsandcomparisons.com/News/ArticlePage.aspx?id=7387" rel="nofollow">Trasylol Public Health Advisory Update</a>; October 3, 2006</li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> U.S. Food and Drug Administration. <a href="http://www.fda.gov/cder/drug/InfoSheets/HCP/aprotininHCP.htm" class="external text" title="http://www.fda.gov/cder/drug/InfoSheets/HCP/aprotininHCP.htm" rel="nofollow">Information for Healthcare Professionals; Aprotinin (marketed as Trasylol)</a>. Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../o/c/t/October_30.html" title="October 30">10-30</a>.</li>
<li id="_note-6"><b><a href="#_ref-6" title="">^</a></b> Kraut H, Frey EK, Bauer E. <i>Z Physiol Chem</i> 1928;175:97-114.</li>
<li id="_note-7"><b><a href="#_ref-7" title="">^</a></b> Kunitz M, Northrup J. Isolation from beef pancreas of crystalline trypsinogen, trypsin, trypsin inhibitor, and an inhibitor trypsin compound. <i>J Gen Physiol</i> 1936;19:991-1007. <a href="http://www.jgp.org/cgi/reprint/19/6/991" class="external text" title="http://www.jgp.org/cgi/reprint/19/6/991" rel="nofollow">PDF</a>.</li>
<li id="_note-8"><b><a href="#_ref-8" title="">^</a></b> Kraut H, Bhargava N. Versuche zur Isolierung des Kallikrein-Inaktivators aus Rinderlunge and seine Identifizierung mit dem Inaktivator aus Rinderparotis. <i>Z Physiol Chem</i> 1964;328:231-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14330402" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14330402">PMID 14330402</a>.</li>
<li id="_note-9"><b><a href="#_ref-9" title="">^</a></b> Nugent FW, Warren KW, Jonasson H, Garciadeparedes G. Early experience with trasylol in the treatment of acute pancreatitis. <i>South Med J</i> 1964;57:1317-21. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14195953" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14195953">PMID 14195953</a>.</li>
<li id="_note-10"><b><a href="#_ref-10" title="">^</a></b> Tice DA, Worth Jr MH, Clauss RH, Reed GH. The inhibition of trasylol of fibrinolytic activity associated with cardiovascular operations. <i>Surg Gynecol Obstet</i> 1964;119:71-4. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14179354" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14179354">PMID 14179354</a>.</li>
</ol>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/p/r/Aprotinin.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.trasylol.com/" class="external text" title="http://www.trasylol.com/" rel="nofollow">Trasylol.com</a> (official Bayer website)</li>
<li><a href="../../../c/h/e/Wikipedia%7EChemical_sources_67a4.html" title="Wikipedia:Chemical sources">Links to external chemical sources</a></li>
</ul>

<!-- 
Pre-expand include size: 34040 bytes
Post-expand include size: 10109 bytes
Template argument size: 4036 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/p/r/Aprotinin.html">http://en.wikipedia.org../../../a/p/r/Aprotinin.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/n/t/Category%7EAntifibrinolytics_431f.html" title="Category:Antifibrinolytics">Antifibrinolytics</a></span> | <span dir='ltr'><a href="../../../p/r/o/Category%7EProteins_5bd5.html" title="Category:Proteins">Proteins</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/p/r/Aprotinin.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/p/r/Talk%7EAprotinin_90d0.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Aprotinin">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/p/r/Aprotinin.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/a/p/r/Aprotynina.html">Polski</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 20:50, 12 March 2007 by Wikipedia user <a href="../../../a/4/b/User%7EA4bot_20ff.html" title="User:A4bot">A4bot</a>. Based on work by Wikipedia user(s) <a href="../../../d/r/2E/User%7EDr.michael.benjamin_a470.html" title="User:Dr.michael.benjamin">Dr.michael.benjamin</a>, <a href="../../../k/j/a/User%7EKjaergaard_efff.html" title="User:Kjaergaard">Kjaergaard</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../b/e/e/User%7EBeetstra_df14.html" title="User:Beetstra">Beetstra</a>, Doc119, <a href="../../../e/v/e/User%7EEveryking_5c9e.html" title="User:Everyking">Everyking</a>, <a href="../../../g/z/u/User%7EGzuckier_c12c.html" title="User:Gzuckier">Gzuckier</a>, Tonbo, <a href="../../../b/w/h/User%7EBwhack_e9d6.html" title="User:Bwhack">Bwhack</a>, <a href="../../../a/l/t/User%7EAlteripse_f1cb.html" title="User:Alteripse">Alteripse</a>, <a href="../../../a/e/d/User%7EAED_76b1.html" title="User:AED">AED</a>, <a href="../../../h/a/s/User%7EHasharBot_fdaa.html" title="User:HasharBot">HasharBot</a>, <a href="../../../a/n/d/User%7EAndre_Engels_23d0.html" title="User:Andre Engels">Andre Engels</a>, <a href="../../../s/k/y/User%7ESkysmith_c555.html" title="User:Skysmith">Skysmith</a>, <a href="../../../t/e/r/User%7ETerrace4_4860.html" title="User:Terrace4">Terrace4</a> and MonheitLaw and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
